The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse ...

Amid the company’s efforts to resolve issues raised during an FDA inspection early last year, Novo Nordisk’s operating base ...

The Food and Drug Administration sent a warning letter to the makers of Ozempic and Wegovy for not reporting potential side ...

Novo Nordisk's reports to the FDA spiked shortly after an inspection found the Ozempic producer ignored reports of deaths and ...

Heath Secretary Robert F. Kennedy Jr.’s efforts to overhaul vaccine policy are likely illegal, a Massachusetts District Court ...

Among the unreported adverse events potentially linked to Ozempic are two deaths and one case of “completed suicide,” ...

The agency says the Ozempic and Wegovy maker failed to properly investigate and report serious adverse events, including ...

Novo Nordisk issued a response to an FDA warning letter that cited serious violations in how the company tracked and reported ...

Simtra BioPharma Solutions was issued a warning letter by the FDA after an inspection uncovered a number of problems at the ...

The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic ...

The FDA has issued warnings to 30 telehealth companies for making false or misleading claims regarding compounded GLP-1 products.

COPENHAGEN, March 10 (Reuters) - Novo Nordisk said on Tuesday it had received a warning letter from the U.S. Food and Drug ...